{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":324,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-09-14T18:21:24.973502+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil","slug":"biotech-investing-at-the-earliest-stages-with-sant-ventures-omar-khalil","published_at":"2026-08-24T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/biotech-investing-at-the-earliest-stages-with-sant-ventures-omar-khalil","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/19670223-biotech-investing-at-the-earliest-stages-with-sante-ventures-omar-khalil.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/19670223-biotech-investing-at-the-earliest-stages-with-sante-ventures-omar-khalil.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Omar Khalil, Managing Director at Santé Ventures, describes forming and funding startups and early-stage biotech companies with a focus on clinical data and differentiation as the key value drivers. Omar talks about his interest in 'undruggable targets,' what's happening with the IPO market, an investor shift from biology risk to commercial risk, and building companies through a ve...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Omar Khalil, Managing Director at Santé Ventures…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3365,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/biotech-investing-at-the-earliest-stages-with-sant-ventures-omar-khalil/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/biotech-investing-at-the-earliest-stages-with-sant-ventures-omar-khalil.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}